Enantioselective analysis of ibuprofen enantiomers in mice plasma and tissues by high-performance liquid chromatography with fluorescence detection: Application to a pharmacokinetic study

被引:10
作者
Przejczowska-Pomierny, Katarzyna [1 ]
Wlodyka, Monika [1 ]
Cios, Agnieszka [1 ]
Wyska, Elzbieta [1 ]
机构
[1] Jagiellonian Univ, Med Coll, Dept Pharmacokinet & Phys Pharm, Med 9, PL-30688 Krakow, Poland
关键词
(R; S)-2-(4-isobutylphenyl) propionic acid; Chiracel OJ-H; chiral separation; compartment modelling; normal phase; CHIRAL STATIONARY-PHASE; STEREOSELECTIVE DISPOSITION; MASS-SPECTROMETRY; HPLC; VOLUNTEERS; SEPARATION; URINE; SERUM; ENANTIOSEPARATION; S(+)-IBUPROFEN;
D O I
10.1002/chir.22715
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A direct fluorometric high-performance liquid chromatography (HPLC) method was developed and validated for the analysis of ibuprofen enantiomers in mouse plasma (100 mu l) and tissues (brain, liver, kidneys) using liquid-liquid extraction and 4-tertbutylphenoxyacetic acid as an internal standard. Separation of enantiomers was accomplished in a Chiracel OJ-H chiral column based on cellulose tris(4-methylbenzoate) coated on 5 mu m silica-gel, 250 x 4.6 mm at 22 degrees C with a mobile phase composed of n-hexane, 2-propanol, and trifluoroacetic acid that were delivered in gradient elution at a flow rate of 1 ml min(-1). A fluorometric detector was set at: lambda(excit). = 220 nm and lambda(emis). = 290 nm. Method validation included the evaluation of the selectivity, linearity, lower limit of quantification (LLOQ), within-run and between-run precision and accuracy. The LLOQ for the two enantiomers was 0.125 mu g ml(-1) in plasma, 0.09 mu g g(-1) in brain, and 0.25 mu g g(-1) in for liver and kidney homogenates. The calibration curves showed good linearity in the ranges of each enantiomers: from 0.125 to 35 mu g ml(-1) for plasma, 0.09-1.44 mu g g(-1) for brain, and 0.25-20 mu g g(-1) for liver and kidney homogenates. The method was successfully applied to a pharmacokinetic study of ibuprofen enantiomers in mice treated i. v. with 10 mg kg(-1) of racemate.
引用
收藏
页码:500 / 511
页数:12
相关论文
共 42 条
[1]   STEREOSELECTIVE SYSTEMIC DISPOSITION OF IBUPROFEN ENANTIOMERS IN THE DOG [J].
AHN, HY ;
AMIDON, GL ;
SMITH, DE .
PHARMACEUTICAL RESEARCH, 1991, 8 (09) :1186-1190
[2]   RESOLUTION OF THE ENANTIOMERS OF IBUPROFEN - COMPARISON STUDY OF DIASTEREOMERIC METHOD AND CHIRAL STATIONARY-PHASE METHOD [J].
AHN, HY ;
SHIU, GK ;
TRAFTON, WF ;
DOYLE, TD .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 653 (02) :163-169
[3]   STEREOSELECTIVE DISPOSITION OF IBUPROFEN ENANTIOMERS IN HUMAN CEREBROSPINAL-FLUID [J].
BANNWARTH, B ;
LAPICQUE, F ;
PEHOURCQ, F ;
GILLET, P ;
SCHAEVERBEKE, T ;
LABORDE, C ;
DEHAIS, J ;
GAUCHER, A ;
NETTER, P .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 40 (03) :266-269
[4]   Enantioselective determination of ibuprofen in plasma by high-performance liquid chromatography-electrospray mass spectrometry [J].
Bonato, PS ;
Del Lama, MPFM ;
de Carvalho, R .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 796 (02) :413-420
[5]  
Canaparo R, 2000, BIOMED CHROMATOGR, V14, P219, DOI 10.1002/1099-0801(200006)14:4<219::AID-BMC969>3.0.CO
[6]  
2-Z
[7]   Analysis of ibuprofen enantiomers in rat plasma by liquid chromatography with tandem mass spectrometry [J].
Cavalcanti Cardoso, Juciane Lauren ;
Lanchote, Vera Lucia ;
Marques Pereira, Maria Paula ;
de Moraes, Natalia Valadares ;
Lepera, Jose Salvador .
JOURNAL OF SEPARATION SCIENCE, 2014, 37 (08) :944-949
[8]   METABOLIC STEREOISOMERIC INVERSION OF IBUPROFEN IN MAMMALS [J].
CHEN, CS ;
SHIEH, WR ;
LU, PH ;
HARRIMAN, S ;
CHEN, CY .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1078 (03) :411-417
[9]   PHARMACOKINETICS AND BIOINVERSION OF IBUPROFEN ENANTIOMERS IN HUMANS [J].
CHENG, HY ;
ROGERS, JD ;
DEMETRIADES, JL ;
HOLLAND, SD ;
SEIBOLD, JR ;
DEPUY, E .
PHARMACEUTICAL RESEARCH, 1994, 11 (06) :824-830
[10]   Clinical pharmacokinetics of ibuprofen - The first 30 years [J].
Davies, NM .
CLINICAL PHARMACOKINETICS, 1998, 34 (02) :101-154